#Japan #Kobe #MySherpa #Ryohei Matsumoto #Developmental Disorders

Introduction to Dr. Ryohei Matsumoto's Presentation at JSPN 121st Annual Meeting

Dr. Ryohei Matsumoto, the CEO of MySherpa, will be sharing his extensive insights during the 121st Japanese Society of Psychiatry and Neurology (JSPN) annual meeting. Set to take place from June 19 to 21, 2025, in Kobe, Japan, this event aims to spotlight advancements in psychiatric care and support for children with developmental disabilities. His presentation, entitled "The Role of Psychiatric Experts in Managing Multifunctional Facilities for Children with Developmental Disorders: Insights from Two Facilities," will delve into his experiences with the establishment and management of such critical facilities.

Details of the Presentation

• - Title: The Role of Psychiatric Experts in Managing Multifunctional Facilities for Children with Developmental Disorders: Insights from Two Facilities.
• - Date: June 20, 2025
• - Time: 13:30 - 14:30
• - Venue: Kobe International Conference Center, Room 504

This session is expected to shed light on the strategic role that psychiatric professionals play in addressing the needs of children facing developmental challenges. Dr. Matsumoto aims to provide a comprehensive overview of practical insights that can benefit both practitioners and families involved in this vital area of mental health.

About Dr. Ryohei Matsumoto

Dr. Matsumoto has a distinguished background in psychiatry, having studied at the Kyoto Prefectural University of Medicine. His academic journey led him to earn a medical doctorate through significant contributions to brain imaging research. He has published over 40 papers in prestigious medical journals, including The American Journal of Psychiatry, showcasing his dedication to advancing psychiatric knowledge and care.

Previously, he served as the director of a psychiatric hospital in Nara Prefecture before founding MySherpa in 2016. In recognition of his expertise, he was appointed as a visiting professor at the Kyoto Prefectural University of Medicine in 2024. Currently, he oversees three mental health clinics as the head of a medical corporation, managing around 4,000 consultations per month while continuing to provide direct psychiatric care.

Overview of MySherpa Online Counseling

MySherpa offers an online counseling platform where individuals can access professional mental health support led by a team of clinical psychologists and certified counselors trained by Dr. Matsumoto. The service allows users to choose their counselors or receive recommendations, facilitating a personalized approach to ongoing mental health support.

Key Features of MySherpa:

• - Comfort of online counseling facilitated by expert professionals.
• - Continuity in care with the same counselor, enhancing the therapeutic relationship.
• - A diverse range of mental health services tailored to individual needs.

You can explore more about MySherpa through their services here: MySherpa and business solutions for organizations here: MySherpa for Business.

About MySherpa Inc.

MySherpa Inc. has established itself as a leader in online mental health support for both individuals and companies. They provide a robust mental health assistance platform underpinned by psychiatric expertise, ensuring that every counseling session is delivered by qualified professionals. The company boasts a proven track record, with engagement from over 300 organizations, highlighting their impact in promoting mental well-being.

In recognition of their innovative approach, MySherpa was featured in the March 2025 issue of Forbes JAPAN as one of the "30 Next Generation Impact Startups."

Company Overview:

• - Company Name: MySherpa Inc.
• - CEO: Dr. Ryohei Matsumoto (Medical Doctor and Psychiatrist)
• - Headquarters: 1-2-15 Toranomon, Minato-ku, Tokyo, Japan, 10th Floor, Toranomon YS Building
• - Established: July 2016
• - Website: MySherpa Corporate Site
• - Service Site: MySherpa Counseling

Dr. Matsumoto's insights at the JSPN annual meeting promise to be invaluable, reflecting on his expertise to enhance the understanding of psychiatric roles in aiding children with developmental disorders.